title: Mesothelioma: closer to the target?
authors.affiliation: Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, NY 10016, USA. harvey.pass@med.nyu.edu
authors.forename: Harvey I
authors.initials: HI
authors.lastname: Pass
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D000086002:Mesothelioma, Malignant; D010166:Palliative Care; D010997:Pleural Neoplasms / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage*
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide